Top news

View all

Togo introduces human papillomavirus vaccine to protect adolescent girls from the leading cause of cervical cancer

The Government of Togo will introduce the human papillomavirus (HPV) vaccine its into routine immunisation system to prevent cervical cancer on Monday, 4 December 2023. Several other local partners, and the private health sector, are supporting…

Shipments to African countries herald final steps toward broader vaccination against malaria

More than 330,000 doses of WHO-recommended RTS,S malaria vaccine arrived last night in Cameroon – a historic step towards broader vaccination against one of the deadliest diseases for African children.

Increase in Measles Deaths Demands Urgent Action to Save Lives

Since 2001, the Measles and Rubella Partnership (M&RP) has worked with countries to vaccinate millions of children, helping to prevent an estimated 57 million deaths.

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published once a month.

View all

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

Dengue spikes: the view from West Bengal

Amid climate change, vector-borne diseases are spreading at increased rates, across larger areas. West Bengal in India is battling rising rates of mosquito-transmitted dengue fever.

Projected impact of climate change to inform which new vaccines receive Gavi support

For the first time in 2024, climate change risk will rank among the criteria informing Gavi’s Vaccine Investment Strategy (VIS). Here’s what that means.

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter